Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial, also known as ECHS1, is a humangene.[5]
The protein encoded by this gene functions in the second step of the mitochondrial fatty acid beta-oxidation pathway. It catalyzes the hydration of 2-trans-enoyl-coenzyme A (CoA) intermediates to L-3-hydroxyacyl-CoAs. The gene product is a member of the hydratase/isomerase superfamily. It localizes to the mitochondrial matrix. Transcript variants utilizing alternative transcription initiation sites have been described in the literature.[5]
Structure
The ECHS1 gene is approximately 11 kb in length, and is composed of eight exons, with exons I and VIII containing the 5'- and 3'-untranslated regions, respectively. There are two major transcription start sites, located 62 and 63 bp upstream of the translation codon, were mapped by primer extension analysis. The 5'-flanking region of the ECHS1 gene is GC-rich and contains several copies of the SP1 binding motive but no typical TATA or CAAT boxes are apparent. Alu repeat elements have been identified within the region -1052/-770 relative to the cap site and in intron 7.[6] The precursor polypeptide contains 290 amino acid residues, with an N-terminal mitochondrial targeting domain (1-27,28,29) leading to a ragged mature N-terminus. The mRNA has a 5'-untranslated sequence of 21 bp and a 3'-untranslated sequence of 391 bp.[7]
Function
Enoyl-CoA hydratase (ECH) catalyzes the second step in beta-oxidation pathway of fatty acid metabolism. The enzyme is involved in the formation of a β-hydroxyacyl-CoA thioester. The two catalytic glutamic acid residues are believed to act in concert to activate a water molecule, while Gly-141 is proposed to be involved in substrate activation. There are two potent inhibitors of ECHS, which irreversibly inactivate the enzyme via covalent adduct formation.[8]
Clinical significance
Enoyl-CoA hydratase short chain has been confirmed to interact with STAT3, such that ECHS1 specifically represses STAT3 activity by inhibiting STAT3 phosphorylation.[9] STAT3 can act as both an oncogene and a tumor suppressor. ECHS1 itself has shown to occur in many cancers, particularly in hepatocellular carcinoma (HCC) development;[10] both exogenous and endogenous forms of ECHS1 bind to HBs and induce apoptosis as a result. This means that ECHS1 may be used in the future as a therapy for patients with HBV-related hepatitis or HCC.[11]
^Janssen U, Davis EM, Le Beau MM, Stoffel W (March 1997). "Human mitochondrial enoyl-CoA hydratase gene (ECHS1): structural organization and assignment to chromosome 10q26.2-q26.3". Genomics. 40 (3): 470–475. doi:10.1006/geno.1996.4597. PMID9073515.
^Kanazawa M, Ohtake A, Abe H, Yamamoto S, Satoh Y, Takayanagi M, et al. (1993). "Molecular cloning and sequence analysis of the cDNA for human mitochondrial short-chain enoyl-CoA hydratase". Enzyme & Protein. 47 (1): 9–13. doi:10.1159/000468650. PMID8012501.
^Zhu XS, Dai YC, Chen ZX, Xie JP, Zeng W, Lin YY, et al. (2013). "Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of Akt activity". Critical Reviews in Eukaryotic Gene Expression. 23 (3): 275–282. doi:10.1615/critreveukaryotgeneexpr.2013007531. PMID23879543.
^Xiao CX, Yang XN, Huang QW, Zhang YQ, Lin BY, Liu JJ, et al. (March 2013). "ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells". Cancer Letters. 330 (1): 67–73. doi:10.1016/j.canlet.2012.11.030. PMID23178449.
Further reading
Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F, Pasquali C, et al. (December 1992). "Human liver protein map: a reference database established by microsequencing and gel comparison". Electrophoresis. 13 (12): 992–1001. doi:10.1002/elps.11501301201. PMID1286669. S2CID23518983.
Dawson SJ, White LA (1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of Infection. 24 (3): 317–320. doi:10.1016/S0163-4453(05)80037-4. PMID1602151.
Li J, Norwood DL, Mao LF, Schulz H (1991). "Mitochondrial metabolism of valproic acid". Biochemistry. 30 (2): 388–394. doi:10.1021/bi00216a012. PMID1988037.
Jackson S, Schaefer J, Middleton B, Turnbull DM (1995). "Characterisation of a novel enzyme of human fatty acid beta-oxidation: a matrix-associated, mitochondrial 2-enoyl-CoA hydratase". Biochemical and Biophysical Research Communications. 214 (1): 247–253. doi:10.1006/bbrc.1995.2281. PMID7669045.
Bruneel A, Labas V, Mailloux A, Sharma S, Royer N, Vinh J, et al. (October 2005). "Proteomics of human umbilical vein endothelial cells applied to etoposide-induced apoptosis". Proteomics. 5 (15): 3876–3884. doi:10.1002/pmic.200401239. PMID16130169. S2CID26007149.
Takahashi M, Watari E, Shinya E, Shimizu T, Takahashi H (August 2007). "Suppression of virus replication via down-modulation of mitochondrial short chain enoyl-CoA hydratase in human glioblastoma cells". Antiviral Research. 75 (2): 152–158. doi:10.1016/j.antiviral.2007.02.002. PMID17395278.
1dub: 2-ENOYL-COA HYDRATASE, DATA COLLECTED AT 100 K, PH 6.5
2dub: ENOYL-COA HYDRATASE COMPLEXED WITH OCTANOYL-COA
2hw5: The crystal structure of human enoyl-coenzyme A (CoA) hydratase short chain 1, ECHS1
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.